Treatment of bipolar disorder: A complex treatment for a multi-faceted disorder

Annals of General Psychiatry

Volumn 6, Issue , 2007, Pages

  Fountoulakis, Konstantinos N ^a   Vieta, Eduard ^b,e   Siamouli, Melina ^a   Valenti, Marc ^b,e   Magiria, Stamatia ^a   Oral, Timucin ^c   Fresno, David ^b,e   Giannakopoulos, Panteleimon ^d   Kaprinis, George S ^a  

^a ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

^b UNIVERSITY OF BARCELONA   (Spain)

^c Bakirkoy State Teaching and Research Hospital for Neuropsychiatry   (Turkey)

^d UNIVERSITY OF GENEVA   (Switzerland)

^e INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; FLUOXETINE; FLUPENTIXOL; GABAPENTIN; HALOPERIDOL; ICOSAPENTAENOIC ACID; LAMOTRIGINE; LITHIUM SALT; MONOAMINE OXIDASE INHIBITOR; MOOD STABILIZER; NEUROLEPTIC AGENT; OLANZAPINE; OXCARBAZEPINE; PLACEBO; QUETIAPINE; RILUZOLE; RISPERIDONE; SEROTONIN UPTAKE INHIBITOR; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VALPROIC ACID; VENLAFAXINE; ZIPRASIDONE;

ADJUVANT THERAPY; AKATHISIA; AMINOTRANSFERASE BLOOD LEVEL; ATAXIA; BIPOLAR DEPRESSION; BIPOLAR DISORDER; BIPOLAR MANIA; BLURRED VISION; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; COGNITIVE THERAPY; COMBINATION CHEMOTHERAPY; DIPLOPIA; DIZZINESS; DOSE RESPONSE; DRUG APPROVAL; DRUG BLOOD LEVEL; DRUG COMPETITION; DRUG DOSE INCREASE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG ERUPTION; DRUG INTOXICATION; DRUG METABOLISM; DYSARTHRIA; DYSPHORIA; ELECTROCONVULSIVE THERAPY; ENDOCRINE DISEASE; EVIDENCE BASED MEDICINE; EXTRAPYRAMIDAL SYMPTOM; FAMILY THERAPY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEMATOLOGIC DISEASE; HUMAN; HYPERPROLACTINEMIA; HYPOTENSION; INCREASED APPETITE; KIDNEY DISEASE; MIXED MANIA AND DEPRESSION; MONOTHERAPY; NEUROLOGIC DISEASE; PRACTICE GUIDELINE; PRIMARY PREVENTION; PROFESSIONAL KNOWLEDGE; PSYCHOEDUCATION; PSYCHOTHERAPY; RAPID CYCLING BIPOLAR DISORDER; RECOMMENDED DRUG DOSE; REVIEW; SEDATION; SIDE EFFECT; SKIN MANIFESTATION; SOMNOLENCE; SUICIDE; THERAPY RESISTANCE; THYROID DISEASE; TRANSCRANIAL MAGNETIC STIMULATION; TREMOR; VERTIGO; WEIGHT GAIN; XEROSTOMIA;

EID: 36448988909     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-6-27     Document Type: Review

References (174)

1. Hirschfeld RM Baker JD Wozniak P Tracy K Sommerville KW The safety and early efficacy of oral-loaded divalproex versus standard-titration divalproex, lithium, olanzapine, and placebo in the treatment of acute mania associated with bipolar disorder J Clin Psychiatry 2003, 64(7):841-846. 12934987
2. Angst J The emerging epidemiology of hypomania and bipolar II disorder. Journal of Affective Disorders 1998, 50:143-151. 10.1016/ S0165-0327(98)00142-6 9858074
3. Vieta E Carne X The use of placebo in clinical trials on bipolar disorder: A new approach for an old debate Psychother Psychosom 2005, 74(1):10-16. 10.1159/000082021 15627851
4. Suppes T Baldessarini RJ Faedda GL Tohen M Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Archives of General Psychiatry 1991, 48:1082-1088. 1845226
5. Faedda GL Baldessarini RJ Tohen M Strakowski SM Waternaux C Episode sequence in bipolar disorder and response to lithium treatment Am J Psychiatry 1991, 148(9):1237-1239. 1883005
6. Maj M Priozzi R Kemali D Long-term outcome of lithium prophylaxis in patients initially classified as complete responders Psychopharmacology (Berl) 1988, 98(4):535-538. 10.1007/BF00441955
7. Cohn JB Collins G Ashbrook E Wernicke JF A comparison of fluoxetine imipramine and placebo in patients with bipolar depressive disorder Int Clin Psychopharmacol 1989, 4(4):313-322. 10.1097/ 00004850-198910000-00006 2607128
8. Rush AJ Rago WV Crismon ML Toprac MG Shon SP Suppes T Miller AL Trivedi MH Swann AC Biggs MM Shores-Wilson K Kashner TM Pigott T Chiles JA Gilbert DA Altshuler KZ Medication treatment for the severely and persistently mentally ill: The Texas Medication Algorithm Project J Clin Psychiatry 1999, 60(5):284-291. 10362434
9. Expert consensus guidelines are released for the treatment of bipolar disorder. Consensus Development Conferences Am Fam Physician 1997, 55(4):1447-1449. 9092295
10. AACAP AACAP official action. Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder J Am Acad Child Adolesc Psychiatry 1997, 36(1):138-157. 9000791
11. Allen MH Currier GW Hughes DH Reyes-Harde M Docherty JP The Expert Consensus Guideline Series. Treatment of behavioral emergencies Postgrad Med 2001:1-88; quiz 89-90 11500996
12. APA Practice guideline for the treatment of patients with bipolar disorder. American Psychiatric Association Am J Psychiatry 1994, 151(12 Suppl):1-36.
13. APA American Psychiatric Association releases treatment guideline for bipolar disease Am Fam Physician 1995, 51(6):1605-1606. 7732956
14. American Psychiatric Association Practice guideline for the treatment of patients with bipolar disorder (revision) Am J Psychiatry 2002, 159(4 Suppl):1-50.
15. Barreira P Duckworth K Goff D Flannery RB Jr. Clinical practice guidelines: The Massachusetts experience in psychiatry Harv Rev Psychiatry 1999, 7(4):230-232. 10.1093/hrp/7.4.230 10579103
16. Gilbert DA Altshuler KZ Rago WV Shon SP Crismon ML Toprac MG Rush AJ Texas Medication Algorithm Project: Definitions, rationale, and methods to develop medication algorithms J Clin Psychiatry 1998, 59(7):345-351. 9714262
17. Dennehy EB Guidelines for treatment of bipolar disorder Curr Psychiatry Rep 2000, 2(4):316-321. 10.1007/s11920-000-0074-7 11122975
18. Goldberg JF Treatment guidelines: Current and future management of bipolar disorder J Clin Psychiatry 2000, 61 Supp 13:12-18. 11153806
19. Goodwin GM Bourgeois MI Conti L Treatment of bipolar depressive mood disorders: Algorithms for pharmacotherapy. Int J Psychiatry Clin Pract 1997, 1:S9-S12.
20. Goodwin GM Evidence-based guidelines for treating bipolar disorder: recommendations from the British Association for Psychopharmacology J Psychopharmacol 2003, 17(2):149-73; discussion 147. 10.1177/ 0269881103017002003 12870562
21. Grunze H Kasper S Goodwin G Bowden C Baldwin D Licht R Vieta E Moller HJ World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of bipolar disorders. Part I: Treatment of bipolar depression World J Biol Psychiatry 2002, 3(3):115-124. 12478876
22. Grunze H Kasper S Goodwin G Bowden C Baldwin D Licht RW Vieta E Moller HJ The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders, Part II: Treatment of Mania World J Biol Psychiatry 2003, 4(1):5-13. 12582971
23. Jobson K International Psychopharmacology Algorithm Project: Algorithms in psychopharmacology Int J Psychiatry Clin Pract 1997, 1:S3-S8.
24. Kusumakar V Yatham LN Parikh SV Bipolar disorder: A summary of clinical issues and treatment options Halifax, Nova Scotia: CANMAT Monograph 1997.
25. Licht RW Vestergaard P Kessing LV Larsen JK Thomsen PH Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark Psychopharmacological treatment with lithium and antiepileptic drugs: Suggested guidelines from the Danish Psychiatric Association and the Child and Adolescent Psychiatric Association in Denmark Acta Psychiatr Scand Suppl 2003, 419:1-22. 10.1034/ j.1600-0447.108.s419.1.x 12974784
26. McClellan J Werry J Practice parameters for the assessment and treatment of children and adolescents with bipolar disorder. American Academy of Child and Adolescent Psychiatry J Am Acad Child Adolesc Psychiatry 1997, 36(10 Suppl):157S-76S. 9432516
27. Montgomery DB ECNP Consensus Meeting March 2000 Nice: Guidelines for investigating efficacy in bipolar disorder. European College of Neuropsychopharmacology Eur Neuropsychopharmacol 2001, 11(1):79-88. 10.1016/S0924-977X(00)00140-1 11300094
28. Rush AJ Crismon ML Kashner TM Toprac MG Carmody TJ Trivedi MH Suppes T Miller AL Biggs MM Shores-Wilson K Witte BP Shon SP Rago WV Altshuler KZ Texas Medication Algorithm Project, phase 3 (TMAP-3): Rationale and study design J Clin Psychiatry 2003, 64(4):357-369. 12716235
29. Sachs GS Printz DJ Kahn DA Carpenter D Docherty JP The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000 Postgrad Med 2000, Spec No:1-104. 10895797
30. Suppes T Calabrese JR Mitchell PB Pazzaglia PJ Potter WZ Zarin DA Algorithms for the treatment of bipolar manic-depressive illness Psychopharmacol Bull 1995, 31(3):469-474. 8668751
31. Suppes T Dennehy EB Swann AC Bowden CL Calabrese JR Hirschfeld RM Keck PE Jr. Sachs GS Crismon ML Toprac MG Shon SP Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000 J Clin Psychiatry 2002, 63(4):288-299. 12004801
32. Suppes T Rush AJ Dennehy EB Crismon ML Kashner TM Toprac MG Carmody TJ Brown ES Biggs MM Shores-Wilson K Witte BP Trivedi MH Miller AL Altshuler KZ Shon SP Texas Medication Algorithm Project, phase 3 (TMAP-3): Clinical results for patients with a history of mania J Clin Psychiatry 2003, 64(4):370-382. 12716236
33. Suppes T Swann AC Dennehy EB Habermacher ED Mason M Crismon ML Toprac MG Rush AJ Shon SP Altshuler KZ Texas Medication Algorithm Project: development and feasibility testing of a treatment algorithm for patients with bipolar disorder J Clin Psychiatry 2001, 62(6):439-447. 11465521
34. O'Dowd A NICE issues new guidance to improve the treatment of bipolar disorder Bmj 2006, 333(7561):220. 1523473 16873857 10.1136/ bmj.333.7561.220
35. Yatham LN Kennedy SH O'Donovan C Parikh S MacQueen G McIntyre R Sharma V Silverstone P Alda M Baruch P Beaulieu S Daigneault A Milev R Young LT Ravindran A Schaffer A Connolly M Gorman CP Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Consensus and controversies Bipolar Disord 2005, 7 Suppl 3:5-69. 15952957
36. Grunze H Kasper S Goodwin G Bowden C Moller HJ The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: Maintenance treatment World J Biol Psychiatry 2004, 5(3):120-135. 10.1080/15622970410029924 15346536
37. Yatham LN Kennedy SH O'Donovan C Parikh SV MacQueen G McIntyre RS Sharma V Beaulieu S Canadian Network for Mood and Anxiety Treatments (CANMAT) guidelines for the management of patients with bipolar disorder: Update 2007 Bipolar Disord 2006, 8(6):721-739. 10.1111/j.1399-5618.2006.00432.x 17156158
38. Frances AJ Docherty JP Kahn DA The Expert Consensus Guideline Series: Treatment of Bipolar Disorder J Clin Psychiatry 1996, 57(suppl12A):1-88.
39. Bauer MS Callahan AM Jampala C Petty F Sajatovic M Schaefer V Wittlin B Powell BJ Clinical practice guidelines for bipolar disorder from the Department of Veterans Affairs J Clin Psychiatry 1999, 60(1):9-21. 10074872
40. Hirschfeld RMA Guideline Watch for the Practice Guideline for the Treatment of Patients With Bipolar Disorder Arlington, VA, American Psychiatric Association 2005.
41. Vieta E Nolen WA Grunze H Licht RW Goodwin G A European perspective on the Canadian guidelines for bipolar disorder Bipolar Disord 2005, 7 Suppl 3:73-76. 15952959
42. Fountoulakis KN Vieta E Sanchez-Moreno J Kaprinis SG Goikolea JM Kaprinis GS Treatment guidelines for bipolar disorder: A critical review J Affect Disord 2005, 86(1):1-10. 10.1016/j.jad.2005.01.004 15820265
43. Geddes JR Burgess S Hawton K Jamison K Goodwin GM Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials Am J Psychiatry 2004, 161(2):217-222. 10.1176/appi.ajp.161.2.217 14754766
44. Baldessarini RJ Tondo L Hennen J Lithium treatment and suicide risk in major affective disorders: Update and new findings J Clin Psychiatry 2003, 64 Suppl 5:44-52. 12720484
45. Calabrese JR Goldberg JF Ketter TA Suppes T Frye M White R DeVeaugh-Geiss A Thompson TR Recurrence in bipolar I disorder: A post hoc analysis excluding relapses in two double-blind maintenance studies Biol Psychiatry 2006, 59(11):1061-1064. 10.1016/j.biopsych.2006.02.034 16769295
46. Prien RF Kupfer DJ Mansky PA Small JG Tuason VB Voss CB Johnson WE Drug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Report of the NIMH Collaborative Study Group comparing lithium carbonate, imipramine, and a lithium carbonate-imipramine combination Arch Gen Psychiatry 1984, 41(11):1096-1104. 6437366
47. Kane JM Quitkin FM Rifkin A Ramos-Lorenzi JR Nayak DD Howard A Lithium carbonate and imipramine in the prophylaxis of unipolar and bipolar II illness: A prospective, placebo-controlled comparison Arch Gen Psychiatry 1982, 39(9):1065-1069. 6810839
48. Bowden CL Brugger AM Swann AC Calabrese JR Janicak PG Petty F Dilsaver SC Davis JM Rush AJ Small JG Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group JAMA 1994, 271(12):918-924. 10.1001/jama.271.12.918 8120960
49. Kessing LV Sondergard L Kvist K Andersen PK Suicide risk in patients treated with lithium Arch Gen Psychiatry 2005, 62(8):860-866. 10.1001/ archpsyc.62.8.860 16061763
50. Cipriani A Pretty H Hawton K Geddes JR Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials Am J Psychiatry 2005, 162(10):1805-1819. 10.1176/appi.ajp.162.10.1805 16199826
51. Calabrese JR Vieta E Shelton MD Latest maintenance data on lamotrigine in bipolar disorder Eur Neuropsychopharmacol 2003 13 Suppl 2:S57-66. 10.1016/S0924-977X(03)00079-8 12957721
52. Goldsmith DR Wagstaff AJ Ibbotson T Perry CM Spotlight on lamotrigine in bipolar disorder CNS Drugs 2004, 18(1):63-67. 10.2165/ 00023210-200418010-00007 14731061
53. Post RM Leverich GS Altshuler L Mikalauskas K Lithium-discontinuation-induced refractoriness: Preliminary observations Am J Psychiatry 1992, 149:1727. 1443252
54. Bowden CL Calabrese JR McElroy SL Gyulai L Wassef A Petty F Pope HG Jr. Chou JC Keck PE Jr. Rhodes LJ Swann AC Hirschfeld RM Wozniak PJ A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group Arch Gen Psychiatry 2000, 57(5):481-489. 10.1001/ archpsyc.57.5.481 10807488
55. Silverstone PH Bell EC Willson MC Dave S Wilman AH Lithium alters brain activation in bipolar disorder in a task- and state-dependent manner: An fMRI study Ann Gen Psychiatry 2005, 4:14. 1188051 16029502 10.1186/ 1744-859X-4-14
56. Calabrese JR Shelton MD Rapport DJ Youngstrom EA Jackson K Bilali S Ganocy SJ Findling RL A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder Am J Psychiatry 2005, 162(11):2152-2161. 10.1176/appi.ajp.162.11.2152 16263857
57. Davis LL Bartolucci A Petty F Divalproex in the treatment of bipolar depression: A placebo-controlled study J Affect Disord 2005, 85(3):259-266. 10.1016/j.jad.2004.09.009 15780695
58. Pope HG Jr. McElroy SL Keck PE Jr. Hudson JI Valproate in the treatment of acute mania. A placebo-controlled study Arch Gen Psychiatry 1991, 48(1):62-68. 1984763
59. Sachs G Chengappa KN Suppes T Mullen JA Brecher M Devine NA Sweitzer DE Quetiapine with lithium or divalproex for the treatment of bipolar mania: A randomized, double-blind, placebo-controlled study Bipolar Disord 2004, 6(3):213-223. 10.1111/j.1399-5618.2004.00115.x 15117400
60. Tohen M Baker RW Altshuler LL Zarate CA Suppes T Ketter TA Milton DR Risser R Gilmore JA Breier A Tollefson GA Olanzapine versus divalproex in the treatment of acute mania Am J Psychiatry 2002, 159(6):1011-1017. 10.1176/appi.ajp.159.6.1011 12042191
61. Welge JA Keck PE Jr. Meinhold JM Predictors of response to treatment of acute bipolar manic episodes with divalproex sodium or placebo in 2 randomized, controlled, parallel-group trials J Clin Psychopharmacol 2004, 24(6):607-612. 10.1097/01.jcp.0000145342.38170.7f 15538121
62. Bowden CL Swann AC Calabrese JR Rubenfaer LM Wozniak PJ Collins MA Abi-Saab W Saltarelli M A randomized, placebo-controlled, multicenter study of divalproex sodium extended release in the treatment of acute mania J Clin Psychiatry 2006, 67(10):1501-1510. 17107240
63. Freeman TW Clothier JL Pazzaglia P Lesem MD Swann AC A double-blind comparison of valproate and lithium in the treatment of acute mania Am J Psychiatry 1992, 149(1):108-111. 1728157
64. Calabrese JR Woyshville MJ Kimmel SE Rapport DJ Predictors of valproate response in bipolar rapid cycling J Clin Psychopharmacol 1993, 13(4):280-283. 10.1097/00004714-199308000-00009 8376616
65. Gyulai L Bowden CL McElroy SL Calabrese JR Petty F Swann AC Chou JC Wassef A Risch CS Hirschfeld RM Nemeroff CB Keck PE Jr. Evans DL Wozniak PJ Maintenance efficacy of divalproex in the prevention of bipolar depression Neuropsychopharmacology 2003, 28(7):1374-1382. 10.1038/ sj.npp.1300190 12784116
66. Puzynski S Klosiewicz L Valproic acid amide in the treatment of affective and schizoaffective disorders J Affect Disord 1984, 6(1):115-121. 10.1016/0165-0327(84)90013-2 6142911
67. Solomon DA Ryan CE Keitner GI Miller IW Shea MT Kazim A Keller MB A pilot study of lithium carbonate plus divalproex sodium for the continuation and maintenance treatment of patients with bipolar I disorder J Clin Psychiatry 1997, 58(3):95-99. 9108809
68. Lerer B Moore N Meyendorff E Cho SR Gershon S Carbamazepine versus lithium in mania: A double-blind study J Clin Psychiatry 1987, 48(3):89-93. 3546274
69. Thase ME Macfadden W Weisler RH Chang W Paulsson B Khan A Calabrese JR Efficacy of quetiapine monotherapy in bipolar I and II depression: A double-blind, placebo-controlled study (the BOLDER II study) J Clin Psychopharmacol 2006, 26(6):600-609. 10.1097/01.jcp.0000248603.76231.b7 17110817
70. Weisler RH Kalali AH Ketter TA A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes J Clin Psychiatry 2004, 65(4):478-484. 15119909
71. Owen RT Extended-release carbamazepine for acute bipolar mania: A review Drugs Today (Barc) 2006, 42(5):283-289. 10.1358/dot.2006.42.5.985635 16801991
72. Ballenger JC Post RM Carbamazepine in manic-depressive illness: A new treatment Am J Psychiatry 1980, 137(7):782-790. 7386656
73. Post RM Uhde TW Roy-Byrne PP Joffe RT Antidepressant effects of carbamazepine Am J Psychiatry 1986, 143(1):29-34. 3510572
74. Hartong EG Moleman P Hoogduin CA Broekman TG Nolen WA Prophylactic efficacy of lithium versus carbamazepine in treatment-naive bipolar patients J Clin Psychiatry 2003, 64(2):144-151. 12633122
75. Denicoff KD Smith-Jackson EE Disney ER Ali SO Leverich GS Post RM Comparative prophylactic efficacy of lithium, carbamazepine, and the combination in bipolar disorder J Clin Psychiatry 1997, 58(11):470-478. 9413412
76. Fritze J Beneke M Lanczik M Schneider B Walden J Carbamazepine as adjunct or alternative to lithium in the prophylaxis of recurrent affective disorders Pharmacopsychiatry 1994, 27:181. 7838887
77. Greil W Kleindienst N Erazo N Muller-Oerlinghausen B Differential response to lithium and carbamazepine in the prophylaxis of bipolar disorder J Clin Psychopharmacol 1998, 18:455. 10.1097/ 00004714-199812000-00007 9864077
78. Coxhead N Silverstone T Cookson J Carbamazepine versus lithium in the prophylaxis of bipolar affective disorder Acta Psychiatr Scand 1992, 85(2):114-118. 10.1111/j.1600-0447.1992.tb01453.x 1543034
79. Post RM Uhde TW Ballenger JC Squillace KM Prophylactic efficacy of carbamazepine in manic-depressive illness Am J Psychiatry 1983, 140(12):1602-1604. 6139957
80. Watkins SE Callender K Thomas DR Tidmarsh SF Shaw DM The effect of carbamazepine and lithium on remission from affective illness Br J Psychiatry 1987, 150:180-182. 3115347
81. Greil W Ludwig-Mayerhofer W Erazo N Schochlin C Schmidt S Engel RR Czernik A Giedke H Muller-Oerlinghausen B Osterheider M Rudolf GA Sauer H Tegeler J Wetterling T Lithium versus carbamazepine in the maintenance treatment of bipolar disorders - a randomised study J Affect Disord 1997, 43(2):151-161. 10.1016/S0165-0327(96)01427-9 9165384
82. Kleindienst N Greil W Differential efficacy of lithium and carbamazepine in the prophylaxis of bipolar disorder: Results of the MAP study Neuropsychobiology 2000 42 Suppl 1:2-10. 10.1159/000054844 11093063
83. Bertilsson L Tomson T Clinical pharmacokinetics and pharmacological effects of carbamazepine and carbamazepine 10,11-epoxide: An update Clin Pharmacokinet 1986, 11:177. 3524954
84. Blackburn SC Oliart AD Garcia Rodriguez LA Perez Gutthann S Antiepileptics and blood dyscrasias: A cohort study Pharmacotherapy 1998, 18:1277. 9855327
85. Perlis RH Baker RW Zarate CA Jr. Brown EB Schuh LM Jamal HH Tohen M Olanzapine versus risperidone in the treatment of manic or mixed States in bipolar I disorder: A randomized, double-blind trial J Clin Psychiatry 2006, 67(11):1747-1753. 17196055
86. Bowden CL Calabrese JR Sachs G Yatham LN Asghar SA Hompland M Montgomery P Earl N Smoot TM DeVeaugh-Geiss J A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder Arch Gen Psychiatry 2003, 60(4):392-400. 10.1001/archpsyc.60.4.392 12695317
87. Brown EB McElroy SL Keck PE Jr. Deldar A Adams DH Tohen M Williamson DJ A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression J Clin Psychiatry 2006, 67(7):1025-1033. 16889444
88. Calabrese JR Bowden CL Sachs G Yatham LN Behnke K Mehtonen OP Montgomery P Ascher J Paska W Earl N DeVeaugh-Geiss J A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder J Clin Psychiatry 2003, 64(9):1013-1024. 14628976
89. Calabrese JR Bowden CL Sachs GS Ascher JA Monaghan E Rudd GD A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group J Clin Psychiatry 1999, 60(2):79-88. 10084633
90. Calabrese JR Suppes T Bowden CL Sachs GS Swann AC McElroy SL Kusumakar V Ascher JA Earl NL Greene PL Monaghan ET A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Lamictal 614 Study Group J Clin Psychiatry 2000, 61(11):841-850. 11105737
91. Goodwin GM Bowden CL Calabrese JR Grunze H Kasper S White R Greene P Leadbetter R A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance in bipolar I disorder J Clin Psychiatry 2004, 65(3):432-441. 15096085
92. Ichim L Berk M Brook S Lamotrigine compared with lithium in mania: A double-blind randomized controlled trial Ann Clin Psychiatry 2000, 12(1):5-10. 10.1023/A:1009066725103 10798820
93. McElroy SL Zarate CA Cookson J Suppes T Huffman RF Greene P Ascher J A 52-week, open-label continuation study of lamotrigine in the treatment of bipolar depression J Clin Psychiatry 2004, 65(2):204-210. 15003074
94. Pande AC Crockatt JG Janney CA Werth JL Tsaroucha G Gabapentin in bipolar disorder: A placebo-controlled trial of adjunctive therapy. Gabapentin Bipolar Disorder Study Group Bipolar Disord 2000, 2(3 Pt 2):249-255. 10.1034/j.1399-5618.2000.20305.x 11249802
95. Vieta E Manuel Goikolea J Martinez-Aran A Comes M Verger K Masramon X Sanchez-Moreno J Colom F A double-blind, randomized, placebo-controlled, prophylaxis study of adjunctive gabapentin for bipolar disorder J Clin Psychiatry 2006, 67(3):473-477. 16649836
96. Wang PW Santosa C Schumacher M Winsberg ME Strong C Ketter TA Gabapentin augmentation therapy in bipolar depression Bipolar Disord 2002, 4(5):296-301. 10.1034/j.1399-5618.2002.01211.x 12479661
97. Kushner SF Khan A Lane R Olson WH Topiramate monotherapy in the management of acute mania: Results of four double-blind placebo-controlled trials Bipolar Disord 2006, 8(1):15-27. 10.1111/ j.1399-5618.2006.00276.x 16411977
98. Perlis RH Welge JA Vornik LA Hirschfeld RM Keck PE Jr. Atypical antipsychotics in the treatment of mania: A meta-analysis of randomized, placebo-controlled trials J Clin Psychiatry 2006, 67(4):509-516. 16669715
99. Rendell JM Gijsman HJ Bauer MS Goodwin GM Geddes GR Risperidone alone or in combination for acute mania Cochrane Database Syst Rev 2006:CD004043. 16437472
100. Gopal S Steffens DC Kramer ML Olsen MK Symptomatic remission in patients with bipolar mania: Results from a double-blind, placebo-controlled trial of risperidone monotherapy J Clin Psychiatry 2005, 66(8):1016-1020. 16086617
101. Hirschfeld RM Keck PE Jr. Kramer M Karcher K Canuso C Eerdekens M Grossman F Rapid antimanic effect of risperidone monotherapy: A 3-week multicenter, double-blind, placebo-controlled trial Am J Psychiatry 2004, 161(6):1057-1065. 10.1176/appi.ajp.161.6.1057 15169694
102. Khanna S Vieta E Lyons B Grossman F Eerdekens M Kramer M Risperidone in the treatment of acute mania: Double-blind, placebo-controlled study Br J Psychiatry 2005, 187:229-234. 10.1192/bjp.187.3.229 16135859
103. Nierenberg AA Ostacher MJ Calabrese JR Ketter TA Marangell LB Miklowitz DJ Miyahara S Bauer MS Thase ME Wisniewski SR Sachs GS Treatment-resistant bipolar depression: A STEP-BD equipoise randomized effectiveness trial of antidepressant augmentation with lamotrigine, inositol, or risperidone Am J Psychiatry 2006, 163(2):210-216. 10.1176/ appi.ajp.163.2.210 16449473
104. Sachs GS Grossman F Ghaemi SN Okamoto A Bowden CL Combination of a mood stabilizer with risperidone or haloperidol for treatment of acute mania: a double-blind, placebo-controlled comparison of efficacy and safety Am J Psychiatry 2002, 159(7):1146-1154. 10.1176/appi.ajp.159.7.1146 12091192
105. Segal J Berk M Brook S Risperidone compared with both lithium and haloperidol in mania: A double-blind randomized controlled trial Clin Neuropharmacol 1998, 21(3):176-180. 9617509
106. Smulevich AB Khanna S Eerdekens M Karcher K Kramer M Grossman F Acute and continuation risperidone monotherapy in bipolar mania: A 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol Eur Neuropsychopharmacol 2005, 15(1):75-84. 10.1016/j.euroneuro.2004.06.003 15572276
107. Yatham LN Grossman F Augustyns I Vieta E Ravindran A Mood stabilisers plus risperidone or placebo in the treatment of acute mania. International, double-blind, randomised controlled trial Br J Psychiatry 2003, 182:141-147. 10.1192/bjp.182.2.141 12562742
108. Baker RW Tohen M Fawcett J Risser RC Schuh LM Brown E Stauffer VL Shao L Tollefson GD Acute dysphoric mania: Treatment response to olanzapine versus placebo J Clin Psychopharmacol 2003, 23(2):132-137. 10.1097/ 00004714-200304000-00005 12640214
109. Baldessarini RJ Hennen J Wilson M Calabrese J Chengappa R Keck PE Jr. McElroy SL Sachs G Vieta E Welge JA Yatham LN Zarate CA Jr. Baker RW Tohen M Olanzapine versus placebo in acute mania: Treatment responses in subgroups J Clin Psychopharmacol 2003, 23(4):370-376. 10.1097/ 01.jcp.0000085410.08426.9a 12920413
110. Berk M Ichim L Brook S Olanzapine compared to lithium in mania: A double-blind randomized controlled trial Int Clin Psychopharmacol 1999, 14(6):339-343. 10.1097/00004850-199911000-00003 10565800
111. Chengappa KN Baker RW Shao L Yatham LN Tohen M Gershon S Kupfer DJ Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania Bipolar Disord 2003, 5(1):1-5. 10.1034/ j.1399-5618.2003.02237.x 12656931
112. Corya SA Perlis RH Keck PE Jr. Lin DY Case MG Williamson DJ Tohen MF A 24-week open-label extension study of olanzapine-fluoxetine combination and olanzapine monotherapy in the treatment of bipolar depression J Clin Psychiatry 2006, 67(5):798-806. 16841630
113. Houston JP Ahl J Meyers AL Kaiser CJ Tohen M Baldessarini RJ Reduced suicidal ideation in bipolar I disorder mixed-episode patients in a placebo-controlled trial of olanzapine combined with lithium or divalproex J Clin Psychiatry 2006, 67(8):1246-1252. 16965203
114. Houston JP Lipkovich IA Ahl J Rotelli MD Baker RW Bowden CL Initial symptoms of manic relapse in manic or mixed-manic bipolar disorder: Post hoc analysis of patients treated with olanzapine or lithium J Psychiatr Res 2005. 16236320
115. Meehan K Zhang F David S Tohen M Janicak P Small J Koch M Rizk R Walker D Tran P Breier A A double-blind, randomized comparison of the efficacy and safety of intramuscular injections of olanzapine, lorazepam, or placebo in treating acutely agitated patients diagnosed with bipolar mania J Clin Psychopharmacol 2001, 21(4):389-397. 10.1097/ 00004714-200108000-00006 11476123
116. Shi L Namjoshi MA Swindle R Yu X Risser R Baker RW Tohen M Effects of olanzapine alone and olanzapine/fluoxetine combination on health-related quality of life in patients with bipolar depression: Secondary analyses of a double-blind, placebo-controlled, randomized clinical trial Clin Ther 2004, 26(1):125-134. 10.1016/S0149-2918(04)90013-6 14996525
117. Suppes T Brown E Schuh LM Baker RW Tohen M Rapid versus non-rapid cycling as a predictor of response to olanzapine and divalproex sodium for bipolar mania and maintenance of remission: Post hoc analyses of 47-week data J Affect Disord 2005, 89(1-3):69-77. 10.1016/ j.jad.2005.07.011 16253344
118. Tohen M Calabrese JR Sachs GS Banov MD Detke HC Risser R Baker RW Chou JC Bowden CL Randomized, placebo-controlled trial of olanzapine as maintenance therapy in patients with bipolar I disorder responding to acute treatment with olanzapine Am J Psychiatry 2006, 163(2):247-256. 10.1176/appi.ajp.163.2.247 16449478
119. Tohen M Chengappa KN Suppes T Baker RW Zarate CA Bowden CL Sachs GS Kupfer DJ Ghaemi SN Feldman PD Risser RC Evans AR Calabrese JR Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone Br J Psychiatry 2004, 184:337-345. 10.1192/bjp.184.4.337 15056579
120. Tohen M Chengappa KN Suppes T Zarate CA Jr. Calabrese JR Bowden CL Sachs GS Kupfer DJ Baker RW Risser RC Keeter EL Feldman PD Tollefson GD Breier A Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy Arch Gen Psychiatry 2002, 59(1):62-69. 10.1001/ archpsyc.59.1.62 11779284
121. Tohen M Goldberg JF Gonzalez-Pinto Arrillaga AM Azorin JM Vieta E Hardy-Bayle MC Lawson WB Emsley RA Zhang F Baker RW Risser RC Namjoshi MA Evans AR Breier A A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania Arch Gen Psychiatry 2003, 60(12):1218-1226. 10.1001/archpsyc.60.12.1218 14662554
122. Tohen M Greil W Calabrese JR Sachs GS Yatham LN Oerlinghausen BM Koukopoulos A Cassano GB Grunze H Licht RW Dell'Osso L Evans AR Risser R Baker RW Crane H Dossenbach MR Bowden CL Olanzapine versus lithium in the maintenance treatment of bipolar disorder: A 12-month, randomized, double-blind, controlled clinical trial Am J Psychiatry 2005, 162(7):1281-1290. 10.1176/appi.ajp.162.7.1281 15994710
123. Tohen M Jacobs TG Grundy SL McElroy SL Banov MC Janicak PG Sanger T Risser R Zhang F Toma V Francis J Tollefson GD Breier A Efficacy of olanzapine in acute bipolar mania: A double-blind, placebo-controlled study. The Olanzipine HGGW Study Group Arch Gen Psychiatry 2000, 57(9):841-849. 10.1001/archpsyc.57.9.841 10986547
124. Tohen M Ketter TA Zarate CA Suppes T Frye M Altshuler L Zajecka J Schuh LM Risser RC Brown E Baker RW Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: A 47-week study Am J Psychiatry 2003, 160(7):1263-1271. 10.1176/ appi.ajp.160.7.1263 12832240
125. Tohen M Sanger TM McElroy SL Tollefson GD Chengappa KN Daniel DG Petty F Centorrino F Wang R Grundy SL Greaney MG Jacobs TG David SR Toma V Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group Am J Psychiatry 1999, 156(5):702-709. 10327902
126. Tohen M Vieta E Calabrese J Ketter TA Sachs G Bowden C Mitchell PB Centorrino F Risser R Baker RW Evans AR Beymer K Dube S Tollefson GD Breier A Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression Arch Gen Psychiatry 2003, 60(11):1079-1088. 10.1001/archpsyc.60.11.1079 14609883
127. Zajecka JM Weisler R Sachs G Swann AC Wozniak P Sommerville KW A comparison of the efficacy, safety, and tolerability of divalproex sodium and olanzapine in the treatment of bipolar disorder J Clin Psychiatry 2002, 63(12):1148-1155. 12523875
128. Zhu B Tunis SL Zhao Z Baker RW Lage MJ Shi L Tohen M Service utilization and costs of olanzapine versus divalproex treatment for acute mania: results from a randomized, 47-week clinical trial Curr Med Res Opin 2005, 21(4):555-564. 10.1185/030079905X38259 15899104
129. Rendell JM Gijsman HJ Keck P Goodwin GM Geddes JR Olanzapine alone or in combination for acute mania Cochrane Database Syst Rev 2003:CD004040. 12918000
130. Ketter TA Houston JP Adams DH Risser RC Meyers AL Williamson DJ Tohen M Differential efficacy of olanzapine and lithium in preventing manic or mixed recurrence in patients with bipolar I disorder based on number of previous manic or mixed episodes J Clin Psychiatry 2006, 67(1):95-101. 16426094
131. Bowden CL Grunze H Mullen J Brecher M Paulsson B Jones M Vagero M Svensson K A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder J Clin Psychiatry 2005, 66(1):111-121. 15669897
132. Calabrese JR Keck PE Jr. Macfadden W Minkwitz M Ketter TA Weisler RH Cutler AJ McCoy R Wilson E Mullen J A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression Am J Psychiatry 2005, 162(7):1351-1360. 10.1176/ appi.ajp.162.7.1351 15994719
133. Cookson J Keck PE Jr. Ketter TA Macfadden W Number needed to treat and time to response/remission for quetiapine monotherapy efficacy in acute bipolar depression: Evidence from a large, randomized, placebo-controlled study Int Clin Psychopharmacol 2007, 22(2):93-100. 10.1097/YIC.0b013e3280119dfb 17293709
134. DelBello MP Kowatch RA Adler CM Stanford KE Welge JA Barzman DH Nelson E Strakowski SM A double-blind randomized pilot study comparing quetiapine and divalproex for adolescent mania J Am Acad Child Adolesc Psychiatry 2006, 45(3):305-313. 16540815
135. Delbello MP Schwiers ML Rosenberg HL Strakowski SM A double-blind, randomized, placebo-controlled study of quetiapine as adjunctive treatment for adolescent mania J Am Acad Child Adolesc Psychiatry 2002, 41(10):1216-1223. 10.1097/00004583-200210000-00011 12364843
136. Endicott J Rajagopalan K Minkwitz M Macfadden W A randomized, double-blind, placebo-controlled study of quetiapine in the treatment of bipolar I and II depression: Improvements in quality of life Int Clin Psychopharmacol 2007, 22(1):29-37. 17159457
137. McIntyre RS Brecher M Paulsson B Huizar K Mullen J Quetiapine or haloperidol as monotherapy for bipolar mania--a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial Eur Neuropsychopharmacol 2005, 15(5):573-585. 10.1016/ j.euroneuro.2005.02.006 16139175
138. Vieta E Mullen J Brecher M Paulsson B Jones M Quetiapine monotherapy for mania associated with bipolar disorder: Combined analysis of two international, double-blind, randomised, placebo-controlled studies Curr Med Res Opin 2005, 21(6):923-934. 10.1185/030079905X46340 15969892
139. Yatham LN Paulsson B Mullen J Vagero AM Quetiapine versus placebo in combination with lithium or divalproex for the treatment of bipolar mania J Clin Psychopharmacol 2004, 24(6):599-606. 10.1097/ 01.jcp.0000144887.66319.2f 15538120
140. Potkin SG Keck PE Jr. Segal S Ice K English P Ziprasidone in acute bipolar mania: A 21-day randomized, double-blind, placebo-controlled replication trial J Clin Psychopharmacol 2005, 25(4):301-310. 10.1097/ 01.jcp.0000169068.34322.70 16012271
141. Keck PE Jr. Marcus R Tourkodimitris S Ali M Liebeskind A Saha A Ingenito G A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania Am J Psychiatry 2003, 160(9):1651-1658. 10.1176/appi.ajp.160.9.1651 12944341
142. Keck PE Jr. Versiani M Potkin S West SA Giller E Ice K Ziprasidone in the treatment of acute bipolar mania: A three-week, placebo-controlled, double-blind, randomized trial Am J Psychiatry 2003, 160(4):741-748. 10.1176/appi.ajp.160.4.741 12668364
143. Yocca F McQuade RD Sanchez R Efficacy of aripiprazole in acute mania. A new acute, placbo-controlled study: San Juan, Puerto Rico. 2003.
144. Sachs G Sanchez R Marcus R Stock E McQuade R Carson W Abou-Gharbia N Impellizzeri C Kaplita S Rollin L Iwamoto T Aripiprazole in the treatment of acute manic or mixed episodes in patients with bipolar I disorder: A 3-week placebo-controlled study J Psychopharmacol 2006, 20(4):536-546. 10.1177/0269881106059693 16401666
145. Schaffer A Zuker P Levitt A Randomized, double-blind pilot trial comparing lamotrigine versus citalopram for the treatment of bipolar depression J Affect Disord 2006, 96(1-2):95-99. 10.1016/ j.jad.2006.05.023 16820213
146. Amsterdam JD Garcia-Espana F Venlafaxine monotherapy in women with bipolar II and unipolar major depression J Affect Disord 2000, 59(3):225-229. 10.1016/S0165-0327(99)00149-4 10854639
147. Amsterdam JD Garcia-Espana F Fawcett J Quitkin FM Reimherr FW Rosenbaum JF Schweizer E Beasley C Efficacy and safety of fluoxetine in treating bipolar II major depressive episode J Clin Psychopharmacol 1998, 18(6):435-440. 10.1097/00004714-199812000-00003 9864074
148. Moller HJ Bottlender R Grunze H Streuss A Wittmann J Are antidepressant less effective in the acute treatment of bipolar I compared to unipolar depression? J Affect Disord 2001, 67:141-146. 10.1016/ S0165-0327(01)00449-9 11869761
149. Leverich GS Altshuler LL Frye MA Suppes T McElroy SL Keck PE Jr. Kupka RW Denicoff KD Nolen WA Grunze H Martinez MI Post RM Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers Am J Psychiatry 2006, 163(2):232-239. 10.1176/appi.ajp.163.2.232 16449476
150. Post RM Altshuler LL Frye MA Suppes T Rush AJ Keck PE Jr. McElroy SL Denicoff KD Leverich GS Kupka R Nolen WA Rate of switch in bipolar patients prospectively treated with second-generation antidepressants as augmentation to mood stabilizers Bipolar Disord 2001, 3(5):259-265. 10.1034/j.1399-5618.2001.30505.x 11912569
151. Himmelhoch JM Mulla D Neil JF Detre TP Kupfer DJ Incidence and significance of mixed affective states in a bipolar population Arch Gen Psychiatry 1976, 33:1062-1066. 962490
152. Young LT Joffe RT Robb JC MacQueen GM Marriott M Patelis-Siotis I Double-blind comparison of addition of a second mood stabilizer versus an antidepressant to an initial mood stabilizer for treatment of patients with bipolar depression Am J Psychiatry 2000, 157(1):124-126. 10618026
153. Prien RF NIMH report. Five-center study clarifies use of lithium, imipramine for recurrent affective disorders Hosp Community Psychiatry 1984, 35(11):1097-1098. 6389308
154. Amsterdam JD Shults J Brunswick DJ Hundert M Short-term fluoxetine monotherapy for bipolar type II or bipolar NOS major depression - low manic switch rate Bipolar Disord 2004, 6(1):75-81. 10.1046/ j.1399-5618.2003.00083.x 14996144
155. Ramasubbu R Dose-response relationship of selective serotonin reuptake inhibitors treatment-emergent hypomania in depressive disorders Acta Psychiatr Scand 2001, 104(3):236-8; discusiion 238-9 10.1034/ j.1600-0447.2001.00383.x 11531662
156. Amsterdam JD Shults J Comparison of fluoxetine, olanzapine, and combined fluoxetine plus olanzapine initial therapy of bipolar type I and type II major depression - lack of manic induction J Affect Disord 2005, 87(1):121-130. 10.1016/j.jad.2005.02.018 15923042
157. Keck PE Jr. Corya SA Altshuler LL Ketter TA McElroy SL Case M Briggs SD Tohen M Analyses of treatment-emergent mania with olanzapine/fluoxetine combination in the treatment of bipolar depression J Clin Psychiatry 2005, 66(5):611-616. 15889948
158. Sachs GS Nierenberg AA Calabrese JR Marangell LB Wisniewski SR Gyulai L Friedman ES Bowden CL Fossey MD Ostacher MJ Ketter TA Patel J Hauser P Rapport D Martinez JM Allen MH Miklowitz DJ Otto MW Dennehy EB Thase ME Effectiveness of adjunctive antidepressant treatment for bipolar depression N Engl J Med 2007, 356(17):1711-1722. 10.1056/NEJMoa064135 17392295
159. Vieta E Martinez-Aran A Goikolea JM Torrent C Colom F Benabarre A Reinares M A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers J Clin Psychiatry 2002, 63(6):508-512. 12088162
160. Rouillon F Serrurier D Miller HD Gerard MJ Prophylactic efficacy of maprotiline on unipolar depression relapse J Clin Psychiatry 1991, 52:423-431. 1938979
161. Wittington C Kendall T Fonagy P Cottrell D Cotgrove A Boddington E Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data The Lancet 2004, 363:1341-1345. 10.1016/S0140-6736(04)16043-1
162. Privitera MR Maharaj K Mania from dose-related ziprasidone augmentation of an SSRI J Clin Psychiatry 2003, 64(11):1393-1394. 14658958
163. FDA http://www.fda.gov/cder/drug/antidepressants/default.htm. (accessed 16 October 2006)
164. Bauer MS Wisniewski SR Marangell LB Chessick CA Allen MH Dennehy EB Miklowitz DJ Thase ME Sachs GS Are antidepressants associated with new-onset suicidality in bipolar disorder? A prospective study of participants in the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) J Clin Psychiatry 2006, 67(1):48-55. 16426088
165. Scott J Colom F Vieta E A meta-analysis of relapse rates with adjunctive psychological therapies compared to usual psychiatric treatment for bipolar disorders Int J Neuropsychopharmacol 2006, 10(1):123-129. 10.1017/S1461145706006900 16787554
166. Daly JJ Prudic J Devanand DP Nobler MS Lisanby SH Peyser S Roose SP Sackeim HA ECT in bipolar and unipolar depression: Differences in speed of response Bipolar Disord 2001, 3(2):95-104. 10.1034/ j.1399-5618.2001.030208.x 11333069
167. Small JG Klapper MH Kellams JJ Miller MJ Milstein V Sharpley PH Small IF Electroconvulsive treatment compared with lithium in the management of manic states Arch Gen Psychiatry 1988, 45(8):727-732. 2899425
168. Sikdar S Kulhara P Avasthi A Singh H Combined chlorpromazine and electroconvulsive therapy in mania Br J Psychiatry 1994, 164(6):806-810. 7952988
169. Dolberg OT Dannon PN Schreiber S Grunhaus L Transcranial magnetic stimulation in patients with bipolar depression: A double blind, controlled study Bipolar Disord 2002, 4 Suppl 1:94-95. 10.1034/ j.1399-5618.4.s1.41.x 12479689
170. Nahas Z Kozel FA Li X Anderson B George MS Left prefrontal transcranial magnetic stimulation (TMS) treatment of depression in bipolar affective disorder: A pilot study of acute safety and efficacy Bipolar Disord 2003, 5(1):40-47. 10.1034/j.1399-5618.2003.00011.x 12656937
171. Saba G Rocamora JF Kalalou K Benadhira R Plaze M Lipski H Januel D Repetitive transcranial magnetic stimulation as an add-on therapy in the treatment of mania: A case series of eight patients Psychiatry Res 2004, 128(2):199-202. 10.1016/j.psychres.2004.05.019 15488963
172. Levine J Chengappa KN Brar JS Gershon S Yablonsky E Stapf D Kupfer DJ Psychotropic drug prescription patterns among patients with bipolar I disorder Bipolar Disord 2000, 2(2):120-130. 10.1034/ j.1399-5618.2000.020205.x 11252651
173. Lim PZ Tunis SL Edell WS Jensik SE Tohen M Medication prescribing patterns for patients with bipolar I disorder in hospital settings: adherence to published practice guidelines Bipolar Disord 2001, 3(4):165-173. 10.1034/j.1399-5618.2001.30401.x 11552955
174. Colom F Vieta E Daban C Pacchiarotti I Sanchez-Moreno J Clinical and therapeutic implications of predominant polarity in bipolar disorder J Affect Disord 2006, 93(1-3):13-17. 10.1016/j.jad.2006.01.032 16650901